Destiny Pharma, Glen Goodman and Alan Green
Episode 2062, Sep 17, 2020, 12:50 PM
Destiny Pharma provide updates on the Phase 2b clinical study of their lead asset. Glen Goodman covers this week’s Bitcoin news. Alan Green ON Travis Perkins, Itaconix & Power Metals.
On the Vox Markets Podcast Today: 17th September 2020
Neil Clark, Chief Executive Officer of Destiny Pharma #DEST provides updates on the Phase 2b clinical study of their lead asset and other parts of the business.
Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", covers this week’s Bitcoin, Blockchain and Cryptocurrency news.
(Interview starts at 12 minutes 37 seconds)
Alan Green CEO of Brand Communications talks about: Travis Perkins #TPK, Itaconix #ITX & Power Metals #POW
(Interview starts at 37 minutes 46 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast